The European Patent Office (EPO) has published a new patent application, EP2024180461A1, detailing an integrated system for the ablation of thyroid nodules using both ethanol and radiofrequency methods. The publication date is March 18, 2026, and the applicant and inventor is listed as Hojat Ebrahiminik.

This publication represents a new intellectual property filing concerning medical technology. While it does not impose direct regulatory obligations, it signifies potential future developments in the medical device sector for thyroid treatments. Companies involved in medical device manufacturing or healthcare provision related to thyroid conditions should be aware of this patent filing as it may impact future product development and market exclusivity in the designated European states.